Filing Details
- Accession Number:
- 0001209191-18-033641
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-25 20:08:35
- Reporting Period:
- 2018-05-25
- Accepted Time:
- 2018-05-25 20:08:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298084 | D Thomas Brown | 29890 Tanya Trail Libertyville IL 60048 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-25 | 16,002 | $11.96 | 69,960 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-05-25 | 14,449 | $13.25 | 84,409 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-25 | 30,451 | $61.34 | 53,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2018-05-25 | 16,002 | $0.00 | 16,002 | $11.96 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2018-05-25 | 14,449 | $0.00 | 14,449 | $13.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-12 | 2019-05-12 | No | 4 | M | Direct |
| 0 | 2011-05-12 | 2020-05-12 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $61.34 per share, with a range of $61.065 to $61.81. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
